Center for Thrombosis Research scientists will be presenting the results of three of their research projects at the upcoming (July) International Society for Thrombosis and Hemostasis meetings in Kyto, Japan. The frist of these studies reports on microparticle-associated Tissue Factor in an animal model of pancreatic cancer as a cause of systemic hypercoagulability. The second study suggests that patients receiving heparin flushes during chemotherapy may have sufficient circulating heparin to support platelet activation by bevicizumab. In the third study, we report on the application of a novel method for assessing thrombin generation in whole blood to patients with liver disease.